3647 results for «694»
3647 results
!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice
20 Nov 2023 – From PCR London Valves 2023
Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.
Mitral TEER - Part 1
20 Nov 2023 – From PCR London Valves 2023
Gain valuable insights into Mitral Transcatheter Edge-to-Edge Repair (TEER) with this session: explore the prognostic impact of post-procedural mitral regurgitation and gradient after TEER for primary mitral regurgitation and delve into the evolving landscape of same-day discharge following transcatheter edge-to-edge repair.
Rapid-fire - Challenging TAVI procedures - Part 4
20 Nov 2023 – From PCR London Valves 2023
Join this session for insights and innovative solutions to challenging TAVI procedures: explore the dynamics of peri-procedural ST-elevation myocardial infarction during TAVR, witness shifting left ventricular and hemodynamic physiology, unravel a curious case of valve-in-valve TAVR with a crossability challenge, confront the obstructive dilemma of high...
Challenges in TAVIs, are there guideline recommendations?
20 Nov 2023 – From PCR London Valves 2023
The EAPCI consensus session emphasized the critical role of evaluating and managing coronary artery disease in TAVI candidates, especially in younger and lower-risk patients. Transcatheter heart valve choice influences future coronary access, emphasizing the need for optimized implantation techniques. In cardiogenic shock due to valvular heart...
The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy
17 Sep 2022
Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.
Author
Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data
19 Sep 2022
Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.
Author
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial
07 Nov 2022
Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation.
Author
